首页|期刊导航|中国实验方剂学杂志|基于Notch/eNOS信号通路探讨加味桃核承气汤改善肝窦毛细血管化的作用机制

基于Notch/eNOS信号通路探讨加味桃核承气汤改善肝窦毛细血管化的作用机制OA

Modified Taohe Chengqitang Regulates Notch/eNOS Signaling Pathway to Inhibit Hepatic Sinusoidal Capillarization

中文摘要英文摘要

目的:探讨加味桃核承气汤(JTCT)是否通过抑制肝窦毛细血管化治疗肝纤维化,并验证其具体机制是否与果蝇双翅边缘缺刻同源基因(Notch)信号通路及内皮型一氧化氮合酶(eNOS)信号通路相关.方法:将50只C57BL/6小鼠随机分为正常组,模型组(5 mL·kg-1·3 d-1),加味桃核承气汤低、中、高(JTCT-L、JTCT-M、JTCT-H)剂量组(16.6、33.3、66.6 g·kg-1·d-1).除正常组外,其余小鼠每3 d腹腔注射20%四氯化碳(CCl4)橄榄油溶液,持续4周诱导肝纤维化模型.同时,JTCT-L、JTCT-M、JTCT-H组分别按剂量每日灌胃给药,连续干预4周(正常组和模型组给予等体积生理盐水灌胃).采用胶原酶体外原位灌注、Percoll密度梯度离心联合选择性去除Kupffer细胞的方法,从大鼠肝脏中分离原代肝窦内皮细胞(LSECs),经细胞表型验证后用于实验.细胞培养至对数生长期后,使用小干扰核糖核酸(siRNA)试剂盒进行瞬时转染以敲低可溶性鸟苷酸环化酶(sGC)的表达.随后使用 siRNA试剂盒对细胞进行瞬时转染,用于敲低可溶性鸟苷酸环化酶(sGC),并在此基础上使用 Notch激动剂Jagged-1.采用细胞增殖活性检测试剂盒(CCK-8)检测JTCT对LSECs的细胞增殖抑制作用,采用实时荧光定量聚合酶链式反应(Real-time PCR)和蛋白免疫印迹法(Western blot)检测Notch信号通路和eNOS信号通路相关基因和蛋白的表达,采用荧光探针荧光钙指示剂4/乙酰氧甲基酯(Fluo-4/AM)标记细胞内二价钙离子(Ca2+).结果:与正常组比较,模型组小鼠肝组织出现脂肪样变性、炎症细胞浸润、肝细胞变性坏死、小叶结构紊乱及纤维组织增生;血清羟脯氨酸(Hyp)含量及丙氨酸氨基转移酶(ALT)及天冬氨酸氨基转氨酶(AST)水平均显著升高(P<0.01);Notch1、多毛分裂增强子1(Hes1)、分化簇31(CD31)、血管性血友病因子(vWF)表达显著升高(P<0.01),磷酸化(p)-eNOS/eNOS和sGC表达显著降低(P<0.01).与模型组比较,JTCT各剂量组小鼠血清 Hyp 含量及 ALT、AST 水平均显著降低(P<0.01);肝组织 Notch1、Hes1、CD31、vWF 表达降低(P<0.05,P<0.01),p-eNOS/eNOS 和 sGC 表达明显升高(P<0.05,P<0.01),其中以 JTCT-H 组改善效果最显著(P<0.01).体外实验,与LSEC-1day组比较,LSEC-5day组 Notch1、Hes1、CD31、vWF表达显著升高(P<0.01),p-eNOS/eNOS和 sGC表达显著降低(P<0.01);细胞内Ca2+浓度显著升高(P<0.01).与LSEC-5day组比较,JTCT组Notch1、Hes1、CD31、vWF表达显著降低(P<0.01),p-eNOS/eNOS 表达显著升高(P<0.01);细胞内 Ca2+浓度显著降低(P<0.01).Jagged1 组与 Jagged1+JTCT 组 比 较,Notch1、Hes1、eNOS、p-eNOS、CD31、vWF、sGC表达及 Ca2+浓度差异均无统计学意义.与 LSEC-5day组比较,sGC敲除组(sGC-KO)CD31、vWF表达显著升高(P<0.01).sGC-KO组与sGC-KO+JTCT组比较,CD31、vWF表达差异无统计学意义.结论:JTCT通过抑制Notch信号通路的激活、恢复eNOS信号通路活性以抑制LSECs毛细血管化,从而治疗肝纤维化.

Objective:To investigate whether modified Taohe Chengqitang(JTCT)treats liver fibrosis by inhibiting hepatic sinusoidal capillarization,and to verify whether its specific mechanism is related to the Homologous genes responsible for the notches along the edges of Drosophila wings(Notch)signaling pathway and endothelial nitric oxide synthase(eNOS)signaling pathway.Methods:Fifty C57BL/6 mice were randomized into 5 groups:Control,model(5 mL·kg-1·3 d-1),low-dose JTCT,medium-dose JTCT,and high-dose JTCT(JTCT-L,JTCT-M,JTCT-H).Except the control group,the other groups were intraperitoneally injected with 20%carbon tetrachloride(CCl4)olive oil solution every 3 days for 4 weeks to induce liver fibrosis.Meanwhile,JTCT-L,JTCT-M,and JTCT-H groups were administrated with JTCT by gavage at doses of 16.6,33.3,and 66.6 g·kg-1·d-1,respectively,for 4 consecutive weeks(the control and model groups received equal volumes of normal saline by gavage).Primary liver sinusoidal endothelial cells(LSECs)were isolated from rat livers through in situ perfusion of collagenase,Percoll density gradient centrifugation,and selective removal of Kupffer cells.After verification of cell phenotype,LSECs were used for experiments.For cells at the logarithmic growth phase,the small interfering RNA(siRNA)kit was used to knock down the expression of soluble guanylate cyclase(sGC)through transient transfection.Subsequently,the Notch agonist Jagged-1 was applied.Cell counting kit-8(CCK-8)was used to examine the cytotoxicity of JTCT on LSECs.Real-time PCR and Western blot were employed to measure the expression of molecules in the Notch and eNOS signaling pathways at mRNA and protein levels,respectively.Intracellular Ca2+was labeled with the fluorescent probe Fluo-4 acetoxymethyl ester(Fluo-4/AM).Results:The animal experiment showed that compared with the control group,the model group exhibited hepatic steatosis,inflammatory cell infiltration,hepatocyte degeneration and necrosis,lobular structural disorder,and fibrous tissue hyperplasia in the mouse liver tissue,significantly elevated serum levels of hydroxyproline(Hyp),alanine transaminase(ALT),and aspartate transaminase(AST)(P<0.01),significantly upregulated expression levels of Notch1,Hes family bHLH transcription factor 1(Hes1),Cluster of Differentiation 31(CD31),and von Willebrand factor(vWF)(P<0.01),and significantly downregulated phosphorylate(p)-eNOS/eNOS ratio and sGC expression(P<0.01).Compared with the model group,all the JTCT groups showed significantly reduced serum Hyp,ALT,and AST levels(P<0.01),downregulated expression of Notch1,Hes1,CD31,and vWF(P<0.05,P<0.01),and upregulated p-eNOS/eNOS ratio and sGC expression(P<0.05,P<0.01)in the liver tissue,with the JTCT-H group showing the most significant changes(P<0.01).The cell experiment showed that compared with the LSEC-1day group,the LSEC-5day group exhibited significantly increased expression of Notch1,Hes1,CD31,and vWF(P<0.01),significantly decreased p-eNOS/eNOS ratio and sGC expression(P<0.01),and elevated intracellular Ca2+concentration(P<0.01).Compared with the LSEC-5day group,the JTCT group showed decreased expression of Notch1,Hes1,CD31,and vWF(P<0.01),significantly increased p-eNOS/eNOS ratio(P<0.01),and significantly reduced intracellular Ca2+concentration(P<0.01).No significant differences were observed in the expression of Notch1,Hes1,eNOS,p-eNOS,CD31,vWF,sGC,or intracellular Ca2+concentration between the Jagged1 group and the Jagged1+JTCT group.Compared with the LSEC-5day group,the sGC knockout group(sGC-KO)showed significantly increased expression of CD31 and vWF(P<0.01).There was no significant difference in CD31 or vWF expression between the sGC-KO group and the sGC-KO+JTCT group.Conclusion:JTCT inhibits the activation of the Notch signaling pathway and restores the activity of the eNOS signaling pathway to suppress sinusoidal capillarization of LSECs,thereby treating liver fibrosis.

邵畅;孙希光;黄家欣;叶林茂;梁小凡;何怡;张俊杰

浙江中医药大学 基础医学院,杭州 310053浙江中医药大学 基础医学院,杭州 310053浙江中医药大学 基础医学院,杭州 310053浙江中医药大学 基础医学院,杭州 310053浙江中医药大学 基础医学院,杭州 310053浙江中医药大学 基础医学院,杭州 310053浙江中医药大学 基础医学院,杭州 310053

医药卫生

加味桃核承气汤肝窦毛细血管化果蝇双翅边缘缺刻同源基因(Notch)信号通路内皮型一氧化氮合酶(eNOS)信号通路肝纤维化

modified Taohe Chengqitanghepatic sinusoidal capillarizationHomologous genes responsible for the notches along the edges of Drosophila wings(Notch)signaling pathwayendothelial nitric oxide synthase(eNOS)signaling pathwayliver fibrosis

《中国实验方剂学杂志》 2026 (19)

42-54,13

国家自然科学基金面上项目(81973736)浙江省基础公益研究计划项目(LY23H270008)浙江省新苗人才计划项目(2023R410027)浙江中医药大学研究生拔尖创新人才培育计划项目(2025YJSBJ001)

10.13422/j.cnki.syfjx.20251319

评论